Breaking News

FSSAI Suspends License of Rehaan Healthcare Over Severe Food Safety Violations

The Food Safety and Standards Authority of India (FSSAI) has suspended the manufacturing license of Rehaan Healthcare with immediate effect following critical non-compliances discovered during an inspection of its Health Supplements...

From Laboratory to Patients: ICMR’s Indigenous Biomedical Technologies Move Towards Commercialization

In a significant milestone for India's biomedical innovation ecosystem, the Indian Council of Medical Research (ICMR) has formally...

CISCE Makes Health and Physical Education Compulsory for Classes 9 to 12 Under NEP 2020

The Council for the Indian School Certificate Examinations (CISCE) has announced that Health and Physical Education is now...

Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery

Momentis Surgical has secured 510(k) clearance from the U.S. Food and Drug Administration for a multiport version of its Anovo Surgical...

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Army Hospital R&R Performs First Robotic Stereotactic Brain Stem Biopsy

In a landmark achievement for military medicine, the Neurosurgery Department at the Army Hospital Research & Referral (R&R) has successfully performed the first-ever robotic...

Johnson & Johnson Secures FDA Approval for Dual-Energy Cardiac Ablation Catheter

Johnson & Johnson has secured U.S. regulatory clearance for its newest electrophysiology device, the Dual Energy THERMOCOOL SMARTTOUCH SF Platform. The system lets doctors...

Vertex to Acquire Crinetics Pharmaceuticals for $10.0 Billion, Expanding Rare Endocrine Disease Portfolio

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. announced a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in...

World’s First Once-Weekly Basal Insulin Now in India as Novo Nordisk Launches Awiqli®

In a major milestone for diabetes management, India has become one of the first countries globally to introduce Awiqli, the world’s first once-a-week basal insulin...

Rajasthan Recalls Labour-Inducing Gel Over Quality Test Failure

Rajasthan's Drug Control Department has ordered an immediate recall of a specific batch of Dinoprostone Gel, a critical drug commonly used to induce labour and soften...

skillzMap and PharmaGenDRx Sign Strategic MoU to Accelerate Skill Development in the Pharmaceutical and Life Sciences Sector

PharmaGenDRx, one of India's emerging platforms dedicated to pharmaceutical education, industry engagement, and career development, has signed a Memorandum of Understanding (MoU) with SkillzMap, a leading skill...